Keros Therapeutics (KROS) Times Interest Earned (2019 - 2025)
Keros Therapeutics (KROS) posted Times Interest Earned of -$0.3 for Q4 2025, up 87.38% on a QoQ basis from -$2.37 in Q3 2025, and up 99.49% year-over-year from -$0.15 in Q4 2024.
Keros Therapeutics (KROS) Times Interest Earned (2019 - 2025) Analysis & Trends
Keros Therapeutics' Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.3 for Q4 2025.
- Quarterly Times Interest Earned rose 99.49% year-over-year to -$0.3 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $0.69 (down 99.94% YoY) and the FY2025 annual result came in at $0.69, up 149.07% from the prior year.
- Times Interest Earned was -$0.3 for Q4 2025 at Keros Therapeutics, up from -$2.37 in the prior quarter.
- Across five years, Times Interest Earned topped out at $52.79 in Q4 2023 and bottomed at -$4866.0 in Q4 2021.
- A 5-year average of -$250.38 and a median of -$0.73 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned slumped 90921.37% — and 2025, when it surged 9276.05%.
- Keros Therapeutics' Times Interest Earned stood at -$4866.0 in 2021, then jumped by 100.94% to $45.72 in 2022, then grew by 15.46% to $52.79 in 2023, then slumped by 210.86% to -$58.52 in 2024, then surged by 99.49% to -$0.3 in 2025.
- Business Quant data shows KROS's Times Interest Earned at -$0.3 in Q4 2025, -$2.37 in Q3 2025, and -$7.37 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - | -0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.30 |
| Sep 30, 2025 | -2.37 |
| Jun 30, 2025 | -7.37 |
| Mar 31, 2025 | 33.05 |
| Dec 31, 2024 | -58.52 |
| Sep 30, 2024 | -0.63 |
| Jun 30, 2024 | -0.93 |
| Mar 31, 2024 | -0.36 |
| Dec 31, 2023 | 52.79 |
| Sep 30, 2023 | -1.29 |
| Jun 30, 2023 | -0.83 |
| Mar 31, 2023 | -77.74 |
| Dec 31, 2022 | 45.72 |
| Sep 30, 2022 | -0.58 |
| Jun 30, 2022 | -1.01 |
| Mar 31, 2022 | -120.63 |
| Dec 31, 2021 | -4,866.00 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | -0.22 |
| Mar 31, 2021 | -0.13 |